Brief: Gensight Biologics Announces Publication Of Lumevoq Results

Gensight Biologics SA

17/11/2022 06:37

Nov 17 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS ANNOUNCES PUBLICATION OF RESULTS OF
LUMEVOQ
REFLECT PIVOTAL CLINICAL TRIAL IN PEER-REVIEWED JOURNALS
    * BMJ OPEN OPHTHALMOLOGY PUBLISHES CHARACTERISTICS OF THE
ND4-LHON
STUDY POPULATION BEFORE TREATMENT
    * NEUROLOGY JOURNAL BRAIN PUBLISHES EFFICACY AND SAFETY
RESULTS AT
1.5-YEAR POST TREATMENT

Source text for Eikon:  ID:nBw5qvpTKa 
Further company coverage:  SIGHT.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))